Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ending months of speculation about the future of the embattled maker of Tylenol, Band-Aid and Listerine. Even ...

Guilfoyle's comments come less than a year after she and Donald Trump Jr. ended their engagement Ryan Emberley/amfAR/amfAR via Getty; Frazer Harrison/WireImage Kimberly Guilfoyle reflected on her ...

To Kimberly Williams-Paisley, Diane Keaton wasn't just a co-star. She was also an entertainment industry mother figure who helped launch her career when Williams-Paisley was still just a teen. In a ...

Kimberly-Clark KMB0.30%increase; green up pointing triangle has agreed to buy Kenvue KVUE 0.00%increase; green up pointing triangle for more than $40 billion, combining the maker of Huggies diapers ...

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, Tylenol, is in the crosshairs of the White House. Kimberly-Clark said it would ...

Kimberly-Clark will buy Kenvue for $48.7 billion. A merged Kimberly-Clark-Kenvue could have $32 billion in annual sales and profits as high as $5.5 billion. At Kimberly-Clark's current $40 billion ...

Kimberly-Clark is buying Kenvue, the maker of Tylenol, in a deal worth more than $48 billion, the companies announced on Nov. 3. The deal, which has been approved by each company's board of directors, ...

Kimberly-Clark will acquire Kenvue in a deal valued at nearly $49 billion, both companies announced Monday, combining the maker of Huggies diapers and Kleenex with the owner of Tylenol, which has ...

Consumer giant Kimberly-Clark, which makes Huggies diapers and Kleenex tissues, is buying the company that makes Tylenol and Band-Aids in one of the biggest mergers of the year. The deal, worth almost ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue ...

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United ...